. Author manuscript; available in PMC: 2010 Aug 17.

Published in final edited form as: J Hosp Med. 2008 May;3(3):184–192. doi: 10.1002/jhm.313

TABLE 3.

Physician Specialty, In-Hospital Mortality, and tPA Use in Ischemic Stroke (n=26,925)^*

Characteristics	Unadjusted		Adjusted^†
Characteristics	Odds Ratio (95% CI)	P value	Odds Ratio (95% CI)	P value
Mortality
Attending neurologist	0.32 (0.26–0.39)	<.001	0.60 (0.50–0.72)	<.001
Proportion of admissions to neurology	1.05 (0.85–1.31)	0.64	1.02 (0.79–1.30)	0.90
tPA Use^†
Attending neurologist	1.87 (1.30–2.69)	0.001	2.56 (1.72–3.78)	<.001
Proportion of admissions to neurology	2.32 (0.98–5.49)	0.06	2.47 (1.08–5.65)	0.03

Abbreviations: tPA, tissue plasminogen activator.

Analysis limited to 1999 and to 52 institutions ever coding tPA use for ischemic stroke in 1999 (n=8208).

^†

Analyses adjusted for age, gender, ethnicity, urgency status, illness severity class, and institutional annual acute stroke case volume.